Literature DB >> 33459972

Experience of women with breast cancer undergoing chemotherapy: a systematic review of qualitative research.

Liping Liu1, Yanni Wu1, Weilian Cong1, Mingyu Hu1, Xiaoxia Li1, Chunlan Zhou2.   

Abstract

PURPOSE: Chemotherapy exerts adverse effects on physical, psychological and social functioning in women with breast cancer, which may trigger adaptive activities. For a better understanding of the experience of symptoms associated with chemotherapy and the development of targeted interventions, this study aimed to (a) explore the patient experience of chemotherapy, (b) identify patients' strategies to cope with the side effects and distress and (c) explore the link between their experience and coping strategies.
METHODS: Qualitative studies were included if they explored the experience or coping strategies of women with breast cancer receiving chemotherapy. Instruments from the Joanna Briggs Institute were used to critically appraise the methodological quality, extract data and aggregate findings from the included studies.
RESULTS: Twelve studies presenting findings from 184 women with breast cancer who had received chemotherapy were included in this review. Three synthesized findings were identified from 8 categories based on 91 original findings: (1) Women living with chemotherapy experienced various stressful side effects, and their lives were changed. (2) Supportive care to address needs is essential to help women get through this difficult time. (3) They engaged in numerous types of coping strategies to deal with side effects and adapt to this difficult journey. Moreover, the link between experience of chemotherapy and coping strategies is based on the Lazarus' stress and coping theory.
CONCLUSIONS: Although the experience of women with breast cancer undergoing chemotherapy is individualized, we concluded that the distressing experience related to chemotherapy as a stimulus was viewed as a stressor that demands coping or adaptation. Based on the Lazarus stress and coping theory, the ability of a woman to appraise how chemotherapy changed her life and how she appraises her resources to cope with chemotherapy are essential. The results highlight that pre-chemotherapy care programmes, information support systems, social support groups and individual effective coping strategies are helpful in reducing treatment-related distress levels and enhance self-care effects at home.

Entities:  

Keywords:  Breast neoplasms; Coping strategies; Drug therapy; Review; Support

Mesh:

Year:  2021        PMID: 33459972     DOI: 10.1007/s11136-020-02754-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  38 in total

1.  Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.

Authors:  Sylvia K Plevritis; Diego Munoz; Allison W Kurian; Natasha K Stout; Oguzhan Alagoz; Aimee M Near; Sandra J Lee; Jeroen J van den Broek; Xuelin Huang; Clyde B Schechter; Brian L Sprague; Juhee Song; Harry J de Koning; Amy Trentham-Dietz; Nicolien T van Ravesteyn; Ronald Gangnon; Young Chandler; Yisheng Li; Cong Xu; Mehmet Ali Ergun; Hui Huang; Donald A Berry; Jeanne S Mandelblatt
Journal:  JAMA       Date:  2018-01-09       Impact factor: 56.272

2.  How does adjuvant chemotherapy affect menopausal symptoms, sexual function, and quality of life after breast cancer?

Authors:  Jennifer L Marino; Christobel M Saunders; Laura I Emery; Helena Green; Dorota A Doherty; Martha Hickey
Journal:  Menopause       Date:  2016-09       Impact factor: 2.953

3.  Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.

Authors:  Armiya Sultan; Vivek Choudhary; Arti Parganiha
Journal:  Chronobiol Int       Date:  2017-02-16       Impact factor: 2.877

Review 4.  Long term side effects of adjuvant chemotherapy in patients with early breast cancer.

Authors:  Jessica J Tao; Kala Visvanathan; Antonio C Wolff
Journal:  Breast       Date:  2015-08-20       Impact factor: 4.380

5.  The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.

Authors:  Chantal Quinten; C Kenis; M Hamaker; A Coolbrandt; B Brouwers; L Dal Lago; P Neven; P Vuylsteke; G Debrock; H Van Den Bulck; A Smeets; P Schöffski; A Bottomley; U Wedding; H Wildiers
Journal:  J Geriatr Oncol       Date:  2017-11-20       Impact factor: 3.599

6.  Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.

Authors:  Nadine Zielonke; Andrea Gini; Erik E L Jansen; Ahti Anttila; Nereo Segnan; Antonio Ponti; Piret Veerus; Harry J de Koning; Nicolien T van Ravesteyn; Eveline A M Heijnsdijk
Journal:  Eur J Cancer       Date:  2020-01-10       Impact factor: 9.162

Review 7.  Breast cancer.

Authors:  Nadia Harbeck; Michael Gnant
Journal:  Lancet       Date:  2016-11-17       Impact factor: 79.321

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 9.  Breast Cancer Treatment: A Review.

Authors:  Adrienne G Waks; Eric P Winer
Journal:  JAMA       Date:  2019-01-22       Impact factor: 56.272

Review 10.  Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

Authors:  Ali Montazeri
Journal:  J Exp Clin Cancer Res       Date:  2008-08-29
View more
  5 in total

1.  GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients.

Authors:  Juanzi Zeng; Heming Wu; Donghua Liu; Liang Li; Jiaquan Li; Qiuming Wang; Min Ye; Qingyan Huang; Zhikang Yu; Jinfeng Zhang
Journal:  World J Surg Oncol       Date:  2022-06-22       Impact factor: 3.253

Review 2.  A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.

Authors:  Muhammad Naeem; Muhammad Omer Iqbal; Humaira Khan; Muhammad Masood Ahmed; Muhammad Farooq; Muhammad Moeen Aadil; Mohamad Ikhwan Jamaludin; Abu Hazafa; Wan-Chi Tsai
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

3.  Anticancer Efficacy of 6-Gingerol with Paclitaxel against Wild Type of Human Breast Adenocarcinoma.

Authors:  Kamila Wala; Wojciech Szlasa; Natalia Sauer; Paulina Kasperkiewicz-Wasilewska; Anna Szewczyk; Jolanta Saczko; Nina Rembiałkowska; Julita Kulbacka; Dagmara Baczyńska
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

4.  Clinical Hypnosis in Medical Care: A Mixed-Method Feasibility Study.

Authors:  Sofie Bulling Lind; Henrik Børsting Jacobsen; Ole André Solbakken; Silje Endresen Reme
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

5.  Psychological Distress, Coping Strategies, and Quality of Life in Breast Cancer Patients Under Neoadjuvant Therapy: Protocol of a Systematic Review.

Authors:  Majid Omari; Btissame Zarrouq; Lamiae Amaadour; Zineb Benbrahim; Achraf El Asri; Nawfel Mellas; Karima El Rhazi; Mohammed El Amine Ragala; Karima Halim
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.